What is it about?
Shows that using baselines values appropriately in analysis of covariance can deliver information that is equivalent to having studied more patients.
Featured Image
Why is it important?
Makes a link between analysis of covariance and not only recovering inter-block information but also meta-analysis to show that eschewing modelling is analogous to arbitrarily omitting a clinical trial from your meta-analysis.
Read the Original
This page is a summary of: An unreasonable prejudice against modelling?, Pharmaceutical Statistics, January 2005, Wiley,
DOI: 10.1002/pst.169.
You can read the full text:
Contributors
The following have contributed to this page
